Katalyze AI
Develops AI agent teams for pharmaceutical operations, helping drug companies automate and coordinate operational workflows.
Overview
Katalyze AI is building AI agents for pharmaceutical operations, positioning its product around teams of agents that can support workflows inside pharma organizations. The company targets drugmakers and life sciences operations teams looking to apply automation to operational processes. Its stated differentiator is the use of agent teams rather than single-purpose tools, aimed at coordinating work across pharma operations. Katalyze AI has raised $11 million in one undisclosed round announced on July 6, 2026, providing early funding to develop and commercialize the platform.
Funding History
Katalyze AI thinks the future of pharma operations is teams of AI agents
Frequently Asked Questions
- How much has Katalyze AI raised in total?
- Katalyze AI has raised a total of $11M across 1 funding round.
- Who are Katalyze AI's investors?
- Katalyze AI's investors include Bonfire Ventures.
- What does Katalyze AI do?
- Katalyze AI is building AI agents for pharmaceutical operations, positioning its product around teams of agents that can support workflows inside pharma organizations. The company targets drugmakers and life sciences operations teams looking to apply automation to operational processes. Its stated differentiator is the use of agent teams rather than single-purpose tools, aimed at coordinating work across pharma operations. Katalyze AI has raised $11 million in one undisclosed round announced on July 6, 2026, providing early funding to develop and commercialize the platform.
- Where is Katalyze AI headquartered?
- Katalyze AI is headquartered in San Francisco, CA.
Investors
Related Insights
A comprehensive analysis of Sage's funding history, investors, competitive position, and growth trajectory in the AI Healthcare space.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $35.9 billion raised across 95 deals, with 15 mega-rounds capturing 85.5% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.